{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T10:43:47Z","timestamp":1763376227428,"version":"3.45.0"},"reference-count":39,"publisher":"European Respiratory Society (ERS)","issue":"6","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013506","name":"Kuopion Seudun Hengityss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013506","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation of the Finnish Anti-Tuberculosis Association"},{"name":"North Savo Regional Fund of the Finnish Cultural Foundation"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2025,4,23]]},"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Little is known how subject characteristics affect the airway responsiveness to mannitol, what is the upper limit of a normal response, and what is the reproducibility of the response among healthy subjects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Mannitol testing was performed in 125 healthy, nonsmoking subjects with an age range of 18\u201382\u2005years and an almost equal male-to-female ratio. 25 of them repeated the test. The airway response to mannitol was expressed as the final percentage fall in forced expiratory volume in 1\u2005s (FEV\n                      <jats:sub>1<\/jats:sub>\n                      ) after the final cumulative dose of mannitol (FFALL) and as response-to-dose ratio (RDR), calculated as FFALL divided by the final cumulative dose of mannitol. The upper limits of the normal response were calculated as mean+1.65\u00d7\n                      <jats:sc>sd<\/jats:sc>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Neither age, gender, height, body mass index, atopy, nor baseline FEV\n                      <jats:sub>1<\/jats:sub>\n                      affected the responses statistically significantly. The mean\u00b1\n                      <jats:sc>sd<\/jats:sc>\n                      FFALL was 5.29\u00b14.90% with an upper limit of 13.4%. The mean\u00b1\n                      <jats:sc>sd<\/jats:sc>\n                      RDR was 0.78\u00b10.71% per 100\u2005mg with an upper limit of 1.96% per 100\u2005mg. In the repeated tests, the intraclass correlation coefficients were 0.46 and 0.35, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The subject characteristics do not have a significant effect on the airway responsiveness to mannitol. Therefore, the same upper limits of a normal response can be used in all adult nonsmoking subjects. Among healthy subjects with very mild airway responsiveness to mannitol, FFALL and RDR are poorly reproducible.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/23120541.00125-2025","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T13:02:42Z","timestamp":1748350962000},"page":"00125-2025","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Airway response to mannitol among healthy subjects"],"prefix":"10.1183","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3386-3262","authenticated-orcid":false,"given":"Heikki O.","family":"Koskela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7747-6021","authenticated-orcid":false,"given":"Anne M.","family":"L\u00e4tti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna M.","family":"Nurmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"2025111702401006000_11.6.00125-2025.1","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jaci.2019.04.031","article-title":"Mannitol triggers mast cell-dependent contractions of human small bronchi and prostacyclin bronchoprotection","volume":"144","author":"S\u00e4fholm","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2025111702401006000_11.6.00125-2025.2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/cea.12609","article-title":"Airway responsiveness to mannitol in asthma is associated with chymase-positive mast cells and eosinophilic airway inflammation","volume":"46","author":"Sverrild","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"2025111702401006000_11.6.00125-2025.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.03.001"},{"key":"2025111702401006000_11.6.00125-2025.4","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jaci.2023.11.915","article-title":"Airway hyperresponsiveness correlates with airway TSLP in asthma independent of eosinophilic inflammation","volume":"153","author":"Andreasson","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"2025111702401006000_11.6.00125-2025.5","doi-asserted-by":"crossref","first-page":"w20100","DOI":"10.4414\/smw.2019.20100","article-title":"The sensitivity and specificity of the mannitol bronchial challenge test to identify asthma in different populations: a systematic review","volume":"149","author":"Kernen","year":"2019","journal-title":"Swiss Med Wkly"},{"key":"2025111702401006000_11.6.00125-2025.6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12931-021-01876-9","article-title":"The use of the mannitol test as an outcome measure in asthma intervention studies: a review and practical recommendations","volume":"22","author":"Sverrild","year":"2021","journal-title":"Respir Res"},{"key":"2025111702401006000_11.6.00125-2025.7","doi-asserted-by":"publisher","DOI":"10.1378\/chest.124.4.1341"},{"key":"2025111702401006000_11.6.00125-2025.8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1843.2002.00357.x"},{"key":"2025111702401006000_11.6.00125-2025.9","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-1748"},{"key":"2025111702401006000_11.6.00125-2025.10","doi-asserted-by":"crossref","first-page":"864890","DOI":"10.3389\/falgy.2022.864890","article-title":"Daily inhaled corticosteroids treatment abolishes airway hyperresponsiveness to mannitol in defence and police recruits","volume":"3","author":"Lake","year":"2022","journal-title":"Front Allergy"},{"key":"2025111702401006000_11.6.00125-2025.11","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01296-2021"},{"key":"2025111702401006000_11.6.00125-2025.12","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S2213-2600(21)00226-5","article-title":"Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"9","author":"Diver","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2025111702401006000_11.6.00125-2025.13","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jaci.2022.10.028","article-title":"Eosinophil depletion with benralizumab is associated with attenuated mannitol airway hyperresponsiveness in severe uncontrolled eosinophilic asthma","volume":"151","author":"Chan","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"2025111702401006000_11.6.00125-2025.14","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jaip.2023.12.013","article-title":"Should airway hyper-responsiveness be included in the definition of clinical remission with biologic therapy in severe asthma","volume":"12","author":"Lipworth","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025111702401006000_11.6.00125-2025.15","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-6-144"},{"key":"2025111702401006000_11.6.00125-2025.16","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2003.00226.x"},{"key":"2025111702401006000_11.6.00125-2025.17","doi-asserted-by":"publisher","DOI":"10.1207\/s15327906mbr2603_7"},{"key":"2025111702401006000_11.6.00125-2025.18","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin20.600"},{"key":"2025111702401006000_11.6.00125-2025.19","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-304269"},{"key":"2025111702401006000_11.6.00125-2025.20","doi-asserted-by":"crossref","first-page":"100080","DOI":"10.1016\/j.waojou.2019.100080","article-title":"IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper","volume":"13","author":"Ansotegui","year":"2020","journal-title":"World Allergy Organ J"},{"key":"2025111702401006000_11.6.00125-2025.21","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1590ST"},{"key":"2025111702401006000_11.6.00125-2025.22","doi-asserted-by":"publisher","DOI":"10.1111\/cpf.12237"},{"key":"2025111702401006000_11.6.00125-2025.23","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00101006"},{"key":"2025111702401006000_11.6.00125-2025.24","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1093\/clinchem\/47.12.2137","article-title":"Effect of outliers and nonhealthy individuals on reference interval estimation","volume":"47","author":"Horn","year":"2001","journal-title":"Clin Chem"},{"key":"2025111702401006000_11.6.00125-2025.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90837-8"},{"key":"2025111702401006000_11.6.00125-2025.26","doi-asserted-by":"publisher","DOI":"10.1016\/0010-4825(90)90013-F"},{"key":"2025111702401006000_11.6.00125-2025.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcm.2016.02.012"},{"key":"2025111702401006000_11.6.00125-2025.28","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.rmed.2007.01.008","article-title":"Airway reactivity to inhaled mannitol in cigarette smokers: a longitudinal study","volume":"101","author":"Stolz","year":"2007","journal-title":"Respir Med"},{"key":"2025111702401006000_11.6.00125-2025.29","doi-asserted-by":"crossref","first-page":"1736934","DOI":"10.1080\/20018525.2020.1736934","article-title":"Clinical characteristics of the BREATHE cohort \u2013 a real-life study on patients with asthma and COPD","volume":"7","author":"Backer","year":"2020","journal-title":"Eur Clin Respir J"},{"key":"2025111702401006000_11.6.00125-2025.30","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1007\/s11695-014-1564-8","article-title":"Airway hyperresponsiveness to mannitol in obesity before and after bariatric surgery","volume":"25","author":"Arismendi","year":"2015","journal-title":"Obes Surg"},{"key":"2025111702401006000_11.6.00125-2025.31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00408-024-00755-6","article-title":"The cough response to inhaled mannitol in healthy subjects","volume":"203","author":"Nurmi","year":"2024","journal-title":"Lung"},{"key":"2025111702401006000_11.6.00125-2025.32","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1183\/23120541.00338-2019","article-title":"Cough-provocation tests with hypertonic aerosols","volume":"6","author":"Koskela","year":"2020","journal-title":"ERJ Open Res"},{"key":"2025111702401006000_11.6.00125-2025.33","doi-asserted-by":"crossref","first-page":"833","DOI":"10.4168\/aair.2021.13.6.833","article-title":"Utility of cough provocation tests in chronic cough and respiratory diseases: a comprehensive review and introduction of new reference ranges for the capsaicin test","volume":"13","author":"Koskela","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"key":"2025111702401006000_11.6.00125-2025.34","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00408-014-9612-7","article-title":"Response\u2013dose ratio is a surrogate of cumulative provocative dosage for bronchial provocation tests in asthma","volume":"192","author":"Guan","year":"2014","journal-title":"Lung"},{"key":"2025111702401006000_11.6.00125-2025.35","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.10378"},{"key":"2025111702401006000_11.6.00125-2025.36","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1080\/02770903.2016.1238928","article-title":"Stability of FeNO and airway hyperresponsiveness to mannitol in untreated asthmatics","volume":"54","author":"Udesen","year":"2017","journal-title":"J Asthma"},{"key":"2025111702401006000_11.6.00125-2025.37","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1982.00340200045012"},{"key":"2025111702401006000_11.6.00125-2025.38","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.09518"},{"key":"2025111702401006000_11.6.00125-2025.39","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/clinchem\/hvaa208","article-title":"Choice of statistical tools for outlier removal causes substantial changes in analyte reference intervals in healthy populations","volume":"66","author":"Hickman","year":"2020","journal-title":"Clin Chem"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00125-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T10:40:28Z","timestamp":1763376028000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00125-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,11,17]]},"published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1183\/23120541.00125-2025"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00125-2025","relation":{},"ISSN":["2312-0541"],"issn-type":[{"type":"electronic","value":"2312-0541"}],"subject":[],"published":{"date-parts":[[2025,5,16]]}}}